BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$484M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$450M |
| 3 |
UnitedHealth
UNH
|
+$430M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
Analog Devices
ADI
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$552M |
| 3 |
Netflix
NFLX
|
+$322M |
| 4 |
PepsiCo
PEP
|
+$291M |
| 5 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.39% |
| 2 | Financials | 8.43% |
| 3 | Healthcare | 8.12% |
| 4 | Consumer Discretionary | 8.06% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AARD
3401
Aardvark Therapeutics
AARD
$143M
| $261K | ﹤0.01% |
+34,690
| New | +$390K |
|
3402
Virco
VIRC
$95.2M
| $260K | ﹤0.01% |
27,498
+8,226
| +43% | +$85.7K |
|
3403
Cohu
COHU
$2.81B
| $260K | ﹤0.01% |
17,655
-6,770
| -28% | -$141K |
|
3404
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.03B
| $259K | ﹤0.01% |
8,286
+1,699
| +26% | +$53.9K |
|
3405
AngioDynamics
ANGO
$655M
| $259K | ﹤0.01% |
27,598
-32,423
| -54% | -$341K |
|
3406
CBIZ
CBZ
$2.96B
| $258K | ﹤0.01% |
3,397
-3,595
| -51% | -$289K |
|
3407
Arbor Realty Trust
ABR
$950M
| $257K | ﹤0.01% |
21,874
-20,436
| -48% | -$264K |
|
3408
Gates Industrial Corp
GTES
$7.03B
| $257K | ﹤0.01% |
13,955
-636
| -4% | -$13.1K |
|
3409
PCB Bancorp
PCB
$399M
| $257K | ﹤0.01% |
13,713
-361
| -3% | -$6.97K |
|
|
AXIA
3410
DELISTED
AXIA Energia
AXIA
| $256K | ﹤0.01% |
45,578
+5,406
| +13% | +$27.5K |
|
3411
Lindsay Corp
LNN
$1.17B
| $256K | ﹤0.01% |
2,023
-787
| -28% | -$103K |
|
3412
MillerKnoll
MLKN
$1.62B
| $256K | ﹤0.01% |
13,369
+2,295
| +21% | +$48.8K |
|
3413
Kenon Holdings
KEN
$3.46B
| $256K | ﹤0.01% |
8,000
+200
| +3% | +$6.42K |
|
3414
Fulton Financial
FULT
$4.72B
| $255K | ﹤0.01% |
14,122
-27,361
| -66% | -$533K |
|
|
ATXS
3415
DELISTED
Astria Therapeutics
ATXS
| $254K | ﹤0.01% |
47,560
+41,988
| +754% | +$294K |
|
3416
Enpro
NPO
$7.27B
| $254K | ﹤0.01% |
1,568
-1,446
| -48% | -$260K |
|
3417
Gentherm
THRM
$1.35B
| $253K | ﹤0.01% |
9,463
+1,806
| +24% | +$63.3K |
|
|
LGF.A
3418
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $253K | ﹤0.01% |
28,553
+135
| +0.5% | +$1.22K |
|
3419
Atea Pharmaceuticals
AVIR
$411M
| $252K | ﹤0.01% |
84,361
-12,072
| -13% | -$37.7K |
|
3420
NCR Atleos
NATL
$3.47B
| $251K | ﹤0.01% |
9,516
-1,621
| -15% | -$48.2K |
|
|
SWTX
3421
DELISTED
SpringWorks Therapeutics
SWTX
| $251K | ﹤0.01% |
5,681
-4,038
| -42% | -$186K |
|
3422
Consolidated Water Co
CWCO
$500M
| $250K | ﹤0.01% |
10,209
-600
| -6% | -$16K |
|
3423
InvenTrust Properties
IVT
$2.62B
| $250K | ﹤0.01% |
8,505
-452
| -5% | -$13.3K |
|
3424
Fennec Pharmaceuticals
FENC
$411M
| $250K | ﹤0.01% |
41,014
-3,612
| -8% | -$23.2K |
|
3425
Pliant Therapeutics
PLRX
$66.3M
| $249K | ﹤0.01% |
184,393
+176,881
| +2,355% | +$1.07M |
|
Similar funds
BNP Paribas Financial Markets's Q1 2025 Portfolio in Review
As of Q1 2025, BNP Paribas Financial Markets held 5,672 positions worth $170B, down 4.7% from $178B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets's Q1 2025 filing shows 266 new, 2,026 increased, 2,595 reduced and 297 closed positions. Its largest new stake was First Trust Utilities AlphaDEX Fund: 1,900,000 shares worth $77.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.79B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- BNP Paribas Financial Markets's largest Q1 2025 buy was First Trust Utilities AlphaDEX Fund: 1,900,000 shares worth $77.9M.
- BNP Paribas Financial Markets added most to iShares MSCI USA Quality Factor ETF in Q1 2025, an estimated $484M increase.
- BNP Paribas Financial Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.79B.
- BNP Paribas Financial Markets fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q1 2025, selling an estimated $83.2M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $170B portfolio in Q1 2025.
- BNP Paribas Financial Markets opened 266 new positions and closed 297 in Q1 2025.
- BNP Paribas Financial Markets's portfolio value fell 4.7% quarter-over-quarter to $170B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.